Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 452,407 |
|
|||||
| News | - | ||||||
| Day High | 2.02 | Low High |
|||||
| Day Low | 1.352 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Context Therapeutics Inc | CNTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.23 | -11.27% | 1.81 | 18:10:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.00 | 1.352 | 2.02 | 1.81 | 2.04 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,532 | 452,407 | $ 1.70 | $ 771,081 | - | 0.77 - 2.12 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:27:35 | 1 | $ 1.76 | USD |
Context Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 28.9M | 15.97M | - | 0 | -23.96M | -1.50 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Context Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.00 | 2.12 | 1.352 | 2.02 | 109,314 | -0.19 | -9.50% |
| 1 Month | 1.71 | 2.12 | 1.352 | 1.86 | 261,732 | 0.10 | 5.85% |
| 3 Months | 1.16 | 2.12 | 1.06 | 1.74 | 611,412 | 0.65 | 56.03% |
| 6 Months | 0.9776 | 2.12 | 0.79 | 1.69 | 310,855 | 0.8324 | 85.15% |
| 1 Year | 1.23 | 2.12 | 0.77 | 1.62 | 181,313 | 0.58 | 47.15% |
| 3 Years | 4.44 | 10.87 | 0.47 | 3.81 | 843,443 | -2.63 | -59.23% |
| 5 Years | 4.44 | 10.87 | 0.47 | 3.81 | 843,443 | -2.63 | -59.23% |
Context Therapeutics Description
| Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. |
